Melixol™ is a combination medication manufactured by Square Pharmaceuticals Ltd., Bangladesh. It contains two active ingredients:
Flupentixol (0.5 mg): A typical antipsychotic (neuroleptic) that acts as an antagonist at both dopamine D₁ and D₂ receptors, primarily used to treat schizophrenia and other psychotic disorders.